Publications
Download CSV
Download XLSX
Download TXT
Tables
2024 (841)
2023 (887)
2022 (831)
2021 (892)
2020 (640)
2019 (727)
2018 (651)
2017 (681)
2016 (664)
2015 (429)
2014 (376)
2013 (319)
2012 (244)
2011 (163)
2010 (139)
2000 (2)
1977 (2)
All (8488)
Infrastructure Units
Infrastructure Units list
Infrastructure Units table
Researchers
Subset
Documentation
About
Contact
Software
Login
Fransson S
JSON
CSV
XLSX
TXT
Family name
Fransson
Given name
Susanne
Initials
S
ORCID
ORCID
0000-0002-9713-3074
Affiliations
Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
5 publications
PubMed
DOI
Crossref
METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma.
Vaid R
,
Thombare K
,
Mendez A
, ..., Fischer M,
Mondal T
Nucleic Acids Res.
52
(5) 2648-2671 [2024-03-21; online 2024-01-05]
Bioinformatics Support for Computational Resources [Service]
NGI Short read [Service]
NGI Stockholm (Genomics Production) [Service]
National Genomics Infrastructure [Service]
PubMed
DOI
Crossref
Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer.
Wadensten E,
Wessman S
,
Abel F
, ...,
Gisselsson D
, Genomic Medicine Sweden Childhood Cancer Working Group
JCO Precision Oncology
7
(-) e2300039 [2023-06-00; online 2023-06-29]
Clinical Genomics Stockholm [Service]
NGI Short read [Collaborative]
NGI Stockholm (Genomics Production) [Collaborative]
National Genomics Infrastructure [Collaborative]
PubMed
DOI
Crossref
Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline ALK F1174I Mutation.
Djos A
,
Treis D
,
Fransson S
, ...,
Kogner P
,
Martinsson T
Diagnostics
12
(9) - [2022-09-19; online 2022-09-19]
Bioinformatics Support for Computational Resources [Service]
Clinical Genomics Gothenburg [Service]
PubMed
DOI
Crossref
Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation.
Treis D
,
Umapathy G
,
Fransson S
, ...,
Martinsson T
,
Kogner P
JCO Precision Oncology
6
(6) e2100271 [2022-01-00; online 2022-01-28]
Clinical Genomics Gothenburg [Service]
Clinical Genomics Stockholm [Service]
PubMed
DOI
Crossref
ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation.
Borenäs M, Umapathy G, Lai WY, ...,
Hallberg B
,
Palmer RH
EMBO J.
40
(3) e105784 [2021-02-01; online 2021-01-07]
Clinical Genomics Gothenburg [Collaborative]
Glycoproteomics and MS Proteomics [Service]
SciLifeLab Data Centre
Publications
9.5.1